Higher C-reactive protein a risk factor for incident diabetes: Study
USA: Higher C-reactive protein (CRP) is a risk factor for incident diabetes, states a recent study, however, the excess diabetes burden in Black adults was observed only in those having lower CRP. This suggests inflammation is not likely to be the main driver of this racial disparity. The study was published in the Journal of Clinical Endocrinology & Metabolism on 08 February 2022.
Black adults compared to White adults have been shown to experience more type 2 diabetes mellitus (T2DM) ansl also high inflammatory markers including CRP. Inflammatory markers are linked with incident diabetes risk but the impact of inflammation on racial differences in incident diabetes is not known. To fill this knowdlge gap, Timothy B Plante, Larner College of Medicine at the University of Vermont, Burlington, VT, and colleagues aimed to assess whether CRP mediated the Black-White incident diabetes disparity in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
The study enrolled 30,239 US Black and White adults aged ≥45 years in 2003-2007 with a second visit approximately 10-years later. In participants without baseline baseline diabetes, adjusted sex- and race-stratified risk ratios (RR) for incident diabetes at the second visit by CRP level were calculated. The percent mediation of the racial disparity by CRP was estimated by inverse odds weighting.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.